Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where remedy solutions remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our Pipeline https://financefeeds.com/anthony-scaramucci-sec-ripple-case/